Israel Pharmaceuticals and Healthcare Report Q2 2015

Business Monitor International
February 11, 2015
134 Pages - SKU: BMI5466949
Countries covered: Israel

Israel Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Israel offers an attractive pharmaceutical market, with the government committed to developingthe public healthcare system. An improving intellectual property regime and high penetration of patentedmedicines will be seen as positive by innovative drugmakers. Risks to our outlook include politicaluncertainty and the fiscal deficit, which pose a risk to the government's planned healthcare expenditure.

Headline Expenditure Projections

Pharmaceuticals: ILS7.51bn (USD2.10bn) in 2014 to ILS7.82bn (USD2.06bn) in 2015; +4.16% in localcurrency terms and -1.9% in US dollar terms.

Healthcare: ILS78.62bn (USD21.98bn) in 2014 to ILS83.62bn (USD22.01bn) in 2015; +6.4% in localcurrency terms and +0.1% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Tanzania Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q2 2015BMI View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion ofthe country's National Health Insurance ...
Singapore Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Singapore Pharmaceuticals and Healthcare Report Q2 2015BMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceuticalcompanies due to minimal levels of operational ...
Poland Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Poland Pharmaceuticals and Healthcare Report Q2 2015BMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; anynegative economic developments will have an ...
Peru Pharmaceuticals and Healthcare Report Q2 2015 by Business Monitor International
Peru Pharmaceuticals and Healthcare Report Q2 2015BMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for qualitycontrol will continue to ...
See all reports like this >>

More Israel Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Israel Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Israel Q4 2014BMI View: Even though Israel's tense domestic and external situation threatens overall market stability, itspharmaceutical industry remains well ...
The Pharmaceutical Market: Israel by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Israel (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

More Israel reports

D&B Country Report: Israel by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!